DKK1 and osteoporosis: In addition, serum DKK-1 is increased in multiple myeloma (MM) patients with lytic bone lesions, menopause induced osteoporosis, Paget’s disease, glucocorticoid induced osteoporosis and estrogen deficiency (39, 63-65).